Substituted (oxazolidinon-5-yl-methyl) - 2-thiophene-carboxamides and use thereof in the field of blood coagulation

Details for Australian Patent Application No. 2008266525 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Rester, Ulrich; Degenfeld, Georges; Gnoth, Mark Jean; Heimbach, Dirk; Heitmeier, Stefan; Bauser, Marcus; Saatmann, Uwe; Dittrich-Wengenroth, Elke; Rohrig, Susanne; Tersteegen, Adrian; Gerdes, Christoph; Allerheiligen, Swen

Agent Davies Collison Cave

Pub. Number AU-A-2008266525

PCT Pub. Number WO2008/155032

Priority 10 2007 028 319.0 20.06.07 DE

Filing date 7 June 2008

Wipo publication date 24 December 2008

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4439 (2006.01)

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/155032 Priority application(s): WO2008/155032

15 April 2010 Amendment Made

  The nature of the amendment is: Add co-inventor Kruger, Joachim; Paulsen, Holger

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008266526-Substituted (oxazolidinon-5-yl-methyl) - 2-thiophene-carboxamides and use thereof in the field of blood coagulation

2008266519-Active ingredient suspensions in glycerine